Change search
ReferencesLink to record
Permanent link

Direct link
Four essential drugs needed for quality care of the dying: A Delphi-study based international expert consensus opinion
Umeå University, Faculty of Medicine, Department of Radiation Sciences, Oncology.
Show others and affiliations
2013 (English)In: Journal of Palliative Medicine, ISSN 1096-6218, E-ISSN 1557-7740, Vol. 16, no 1, 38-43 p.Article in journal (Refereed) Published
Abstract [en]

Purpose: The majority of dying patients do not have access to necessary drugs to alleviate their most common symptoms, despite evidence of drug efficacy. Our aim was to explore the degree of consensus about appropriate pharmacological treatment for common symptoms in the last days of life for patients with cancer, among physicians working in specialist palliative care. Material and methods: Within OPCARE9, a European Union seventh framework project aiming to optimize end-of-life cancer care, we conducted a Delphi survey among 135 palliative care clinicians in nine countries. Physicians were initially asked about first and second choice of drugs to alleviate anxiety, dyspnea, nausea and vomiting, pain, respiratory tract secretions (RTS), as well as terminal restlessness. Results: Based on a list of 35 drugs mentioned at least twice in the first round (n = 93), a second Delphi round was performed to determine <= 5 essential drugs for symptom alleviation in the last 48 hours of life that should be available even outside specialist palliative care. There was 80% consensus among the participants (n = 90) regarding morphine, midazolam, and haloperidol as essential drugs. For RTS, there was consensus about use of an antimuscarinic drug, with 9%-27% of the physicians each choosing one of four different drugs. Conclusion: Based on this consensus opinion and other literature, we suggest four drugs that should be made available in all settings caring for dying patients with cancer, to decrease the gap between knowledge and practice: morphine (i.e., an opioid), midazolam (a benzodiazepine), haloperidol (a neuroleptic), and an antimuscarinic.

Place, publisher, year, edition, pages
2013. Vol. 16, no 1, 38-43 p.
National Category
Nursing Cancer and Oncology
URN: urn:nbn:se:umu:diva-66416DOI: 10.1089/jpm.2012.0205ISI: 000313559000009OAI: diva2:607426
Available from: 2013-02-22 Created: 2013-02-19 Last updated: 2013-03-21Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full text

Search in DiVA

By author/editor
Lundquist, GunillaRasmussen Holritz, Birgit
By organisation
OncologyDepartment of Nursing
In the same journal
Journal of Palliative Medicine
NursingCancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 153 hits
ReferencesLink to record
Permanent link

Direct link